AtriCure appoints former J&J executive Shlomi Nachman to Board of Directors

AtriCure, Inc.

Shlomi Nachman elected to AtriCure Board effective January 4, 2024.
Nachman brings >25 years med device experience; was J&J Company Group Chairman for Cardiovascular and Specialty Solutions.
He is an independent director per NASDAQ standards.
He currently serves on boards of several private med device companies and the Beckman Foundation.
CEO Michael Carrel says Nachman's experience in Afib market will be invaluable.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shlomi Nachman

director

ATRC · AtriCure, Inc.

Effective: 2024-01-04
Filed: January 4, 2024, 6:59 PM ET

elected Shlomi Nachman to serve as a director until the next Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Shlomi Nachman was elected as director at AtriCure, Inc..

Action: elected
Role: director

Exact text from the filing

elected Shlomi Nachman to serve as a director until the next Annual Meeting of Stockholders.

View on SEC.gov

AtriCure, Inc. filing history →

Source: SEC EDGAR

accession 0001323885-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.